参考文献:1. Ouyang W M, Ma Q, Li J X, / et al. Cyclin D1 induction through IKB kinase B/nuclear factor-KB pathway is responsible for arseniteinduced increased cell cycle G1-S phase transition in human keratinocytes. Cancer Res, 2005, 65: 9287鈥?294 CrossRef 2. Egloff A M, Vella L A, Finn Q J. Cyclin B1 and other cyclins as tumor antigens in immunosurveillance and immunotherapy of cancer. Cancer Res, 2006, 66: 6鈥?0 CrossRef 3. Massague J. G1 cell-cycle control and cancer. Nature, 2004, 432: 298鈥?06 CrossRef 4. Kastan M B, Bartek J. Cell-cycle checkpoints and cancer. Nature, 2004, 432: 316鈥?23 CrossRef 5. Ohtani N, Yamakoshi K, Takahashi A, / et al. The p16INK4a-RB pathway: Molecular link between cellular senescence and tumor suppression. J Med Invest, 2004, 51: 146鈥?53 CrossRef 6. Jin J, Smith F D, Stark C, / et al. Proteomic, functional, and domain-based analysis of / in vivo binding proteins involved in cytoskeletal regulation and cellular organization. Curr Biol, 2004, 14: 1436鈥?450 CrossRef 7. Lois C, Hong E J, Pease S, / et al. Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science, 2002, 295: 868鈥?72 CrossRef 8. Betticher D C, Heighway J, Hasleton P S, / et al. Prognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer. Br J Cancer, 1996, 73: 294鈥?00 9. Yasmeen A, Berdel W E, Serve H, / et al. E- and A-type cyclins as markers for cancer diagnosis and prognosis. Expert Rev Mol Diagn, 2003, 3: 617鈥?33 CrossRef 10. Ekberg J, Holm C, Jalili S, / et al. Expression of cyclin A1 and cell cycle proteins in hematopoietic cells and acute myeloid leukemia and links to patient outcome. Eur J Haematol, 2005, 75: 106鈥?15 CrossRef 11. Ekberg J, Landberg G, Holm C, / et al. Regulation of the cyclin A1 protein is associated with its differential subcellular localization in hematopoietic and leukemic cells. Oncogene, 2004, 23: 9082鈥?089 CrossRef
作者单位:WenTao Yue (1) XiaoTing Zhao (1) LiNa Zhang (1) ZhiDong Liu (2) Li Ma (1) WenYun Jia (1) Zhe Qian (1) ChunYan Zhang (1) Yue Wang (1) XueHui Yang (1) ShaoFa Xu (2)
1. Department of Cellular Biology, Beijing Chest Hospital, Capital Medical University, Beijing, 101149, China 2. Department of Thoracic Surgery, Beijing Chest Hospital, Capital Medical University, Beijing, 101149, China
文摘
Cyclin Y (CCNY) is a key cell cycle regulator that acts as a growth factor sensor to integrate extracellular signals with the cell cycle machinery. The expression status of CCNY in lung cancer and its clinical significance remain unknown. The data indicates that CCNY may be deregulated in non-small cell lung cancer, where it may act to promote cell proliferation. These studies suggest that CCNY may be a candidate biomarker of NSCLC and a possible therapeutic target for lung cancer treatment.